 | Up a level |
Perroud, Camille; Thurian, Dario; Andres, Martin; Künzi, Arnaud; Wiedemann, Gertrud; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas; Banz, Yara; Porret, Naomi; Rebmann, Ekaterina (2023). Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma. Hematological oncology, 41(5), pp. 912-921. Wiley 10.1002/hon.3208
Ruggeri, Tiphaine; De Wit, Yasmin; Schärz, Noëlia; von Mierlo, Gerard; Angelillo-Scherrer, Anne; Brodard, Justine; Schefold, Joerg C.; Hirzel, Cédric; Jongerius, Ilse; Zeerleder, Sacha (2023). Immunothrombosis and complement activation contribute to disease severity and adverse outcome in COVID-19. Journal of innate immunity, 15(1), pp. 850-864. Karger 10.1159/000533339
Messerli, Christian; Wiedemann, Gertrud; Porret, Naomi; Nagler, Michael; Seipel, Katja; Jeker, Barbara; Novak, Urban; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas (2023). Correlation of peripheral chimeric antigen receptor T-cell (CAR-T cell) mRNA expression levels with toxicities and outcome in patients with diffuse large B-cell lymphoma (DLBCL). Turkish journal of haematology, 40(3), pp. 187-196. Turkish Society of Haematology 10.4274/tjh.galenos.2023.2023.0136
de Boer, Esther Cw; Thielen, Astrid Jf; Langereis, Jeroen D; Kamp, Angela; Brouwer, Mieke C; Oskam, Nienke; Jongsma, Marlieke L; Baral, April J; Spaapen, Robbert M; Zeerleder, Sacha; Vidarsson, Gestur; Rispens, Theo; Wouters, Diana; Pouw, Richard B; Jongerius, Ilse (2023). The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation. Clinical & translational immunology, 12(1), e1436. Wiley 10.1002/cti2.1436
Rovó, Alicia; Gavillet, Mathilde; Drexler, Beatrice; Keller, Peter; Schneider, Jenny Sarah; Colucci, Giuseppe; Beauverd, Yan; van Dorland, Hendrika Anette; Pollak, Matthias; Schmidt, Adrian; De Gottardi, Andrea; Bissig, Marina; Lehmann, Thomas; Duchosal, Michel A; Zeerleder, Sacha (2023). Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones. Frontiers in medicine, 10(1200431), p. 1200431. Frontiers 10.3389/fmed.2023.1200431
Braschler, Thomas R; Zeerleder, Sacha (2022). [Immunglobulin Substitution Therapy in Hematological Patients with secondary Antibody Deficiency]. Therapeutische Umschau, 79(6), pp. 295-300. Hogrefe 10.1024/0040-5930/a001364
Heini, Alexander D; Bacher, Ulrike; Kronig, Marie-Noëlle; Wiedemann, Gertrud; Novak, Urban; Zeerleder, Sacha; Mansouri Taleghani, Behrouz; Daskalakis, Michael; Pabst, Thomas (2022). Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center. Bone marrow transplantation, 57(6), pp. 1010-1012. Springer Nature 10.1038/s41409-022-01658-x
Stanworth, Simon J; Brand, Anneke; Kaveri, Srini V; Vrielink, Hans; Greinacher, Andreas; Domanović, Dragoslav; von Lindern, Marieke; Allard, Shubha; Bayry, Jagadeesh; Bohonek, Milos; Buser, Andreas; Claas, Frans H J; Knutson, Folke; Lozano, Miguel; Olsson, Martin L; Pirenne, France; Rebulla, Paolo; So-Osman, Cynthia; Tissot, Jean-Daniel; Toye, Ashley M; ... (2022). The EHA Research Roadmap: Transfusion Medicine. HemaSphere, 6(2), e670. Wolters Kluwer Health 10.1097/HS9.0000000000000670
Holzer-Schär, Deborah Tabita; Daskalakis, Michael; Mansouri, Behrouz; Rovó, Alicia; Zeerleder, Sacha (2022). Thromboembolic complications in autoimmune hemolytic anemia. European journal of haematology, 108(1), pp. 45-51. Wiley-Blackwell 10.1111/ejh.13710
Delvasto-Nuñez, Laura; Jongerius, Ilse; Zeerleder, Sacha (2021). It takes two to thrombosis: Hemolysis and complement. Blood reviews, 50, p. 100834. Elsevier 10.1016/j.blre.2021.100834
Verheij, Myrddin; Zeerleder, Sacha; Voermans, Carlijn (2021). Heme oxygenase-1: Equally important in allogeneic hematopoietic stem cell transplantation and organ transplantation? Transplant immunology, 68, p. 101419. Elsevier 10.1016/j.trim.2021.101419
Zeerleder, Sacha; Engel, Ruchira; Zhang, Tao; Roem, Dorina; van Mierlo, Gerard; Wagenaar-Bos, Ineke; van Ham, Sija Marieke; Wuhrer, Manfred; Wouters, Diana; Jongerius, Ilse (2021). Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use. Pharmaceuticals, 14(1) MDPI 10.3390/ph14010054
Korkmaz, Halil Ibrahim; Ulrich, Magda M W; Wieringen, Wessel N Van; Doǧan, Hatice; Vlig, Marcel; Emmens, Reindert W; Meyer, Klaas W; Sinnige, Paul; Zeerleder, Sacha; Wouters, Diana; Ham, Marieke S Van; Zuijlen, Paul P M Van; Krijnen, Paul A J; Niessen, Hans W M (2021). C1 Inhibitor Administration Reduces Local Inflammation and Capillary Leakage, Without Affecting Long-term Wound Healing Parameters, in a Pig Burn Wound Model. Anti-inflammatory & anti-allergy agents in medicinal chemistry, 20(2), pp. 150-160. Bentham Science 10.2174/1871523019666200702101513
Nydegger, Anna; Novak, Urban; Kronig, Marie-Noëlle; Legros, Myriam; Zeerleder, Sacha; Banz, Yara; Bacher, Ulrike; Pabst, Thomas (2021). Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients. Cancers, 13(23) MDPI AG 10.3390/cancers13236073
Pabst, Thomas; Joncourt, Raphael; Shumilov, Evgenii; Heini, Alexander; Wiedemann, Gertrud; Legros, Myriam; Seipel, Katja; Schild, Christof; Jalowiec, Katarzyna; Mansouri, Behrouz; Fux, Michaela; Novak, Urban; Porret, Naomi; Zeerleder, Sacha; Bacher, Vera (2020). Analysis of IL-6 serum levels and CAR-T cell specific digital PCR in the context of cytokine release syndrome (CRS). Experimental hematology, 88, 7-14.e3. Elsevier 10.1016/j.exphem.2020.07.003
Levi, Marcel; Cohn, Danny; Zeerleder, Sacha; Dziadzio, Magdalena; Longhurst, Hilary (2019). Long-term effects upon rituximab treatment of acquired angioedema due to C1-inhibitor deficiency. Allergy, 74(4), pp. 834-840. Wiley 10.1111/all.13686
Langedijk, Annefleur C; van Aalst, Mariëlle; Meek, Bob; van Leeuwen, Ester M M; Zeerleder, Sacha; Meijer, Ellen; Hazenberg, Mette D; Grobusch, Martin P; Goorhuis, Abraham (2019). Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation. Vaccine, 37(3), pp. 510-515. Elsevier 10.1016/j.vaccine.2018.11.053
Zeerleder, Sacha; Schroeder, Verena; Lämmle, Bernhard; Wuillemin, Walter A; Hack, C Erik; Kohler, Hans Peter (2007). Factor XIII in severe sepsis and septic shock. Thrombosis research, 119(3), pp. 311-318. Amsterdam: Elsevier 10.1016/j.thromres.2006.02.003
Zeerleder, Sacha; Schroeder, Verena; Hack, C Erik; Kohler, Hans Peter; Wuillemin, Walter A (2006). TAFI and PAI-1 levels in human sepsis. Thrombosis research, 118(2), pp. 205-212. Amsterdam: Elsevier 10.1016/j.thromres.2005.06.007
Voves, Claudia; Wuillemin, Walter A; Zeerleder, Sacha (2006). International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood coagulation & fibrinolysis, 17(6), pp. 445-51. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.mbc.0000240916.63521.2e
Jeker, Barbara; Daskalakis, Michael; Zeerleder, Sacha; Pabst, Thomas; Novak, Urban (January 2021). CAR T Cells: Immuntherapie mit grossem Potenzial. Onkologie & Hämatologie, 2021, pp. 16-19. Prime Public Media AG
